We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

84 hedge funds and large institutions have $360M invested in Korro Bio in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 33 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 9

136% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 14

26% more capital invested

Capital invested by funds: $285M → $360M (+$74.3M)

18% more funds holding

Funds holding: 71 → 84 (+13)

9.03% more ownership

Funds ownership: 91.8% → 100.82% (+9%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
84
Holders Change
+13
Holders Change %
+18.31%
% of All Funds
1.11%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
24
Increased
33
Reduced
14
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$36.3M
2
DCM
Driehaus Capital Management
Illinois
+$17.5M
3
WP
Woodline Partners
California
+$5.25M
4
Franklin Resources
Franklin Resources
California
+$4.72M
5
TLP
Tri Locum Partners
New York
+$4.12M

Top Sellers

Rank Fund Capital Flow
1
EAM
Eventide Asset Management
Massachusetts
-$14.1M
2
CAM
Cormorant Asset Management
Massachusetts
-$8.88M
3
Citadel Advisors
Citadel Advisors
Florida
-$8.19M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$2.43M
5
Verition Fund Management
Verition Fund Management
Connecticut
-$1.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$2.31M +$140K +2,717 +5%
ACM
27
ADAR1 Capital Management
Texas
$2.21M +$438K +8,527 +17%
Walleye Capital
28
Walleye Capital
New York
$1.57M +$2.12M +41,228 New
RSCM
29
Rock Springs Capital Management
Maryland
$1.36M – – –
O
30
OrbiMed
New York
$1.23M +$1.66M +32,400 New
Morgan Stanley
31
Morgan Stanley
New York
$1.09M +$268K +5,207 +22%
N
32
Nuveen
North Carolina
$1.08M +$880K +17,131 +153%
Goldman Sachs
33
Goldman Sachs
New York
$887K +$539K +10,487 +82%
Marshall Wace
34
Marshall Wace
United Kingdom
$703K +$949K +18,461 New
Charles Schwab
35
Charles Schwab
California
$666K -$3.55K -69 -0.4%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$563K +$22.4K +435 +3%
Wellington Management Group
37
Wellington Management Group
Massachusetts
$554K +$77.1K +1,501 +12%
William Blair & Company
38
William Blair & Company
Illinois
$491K +$35.7K +695 +6%
Barclays
39
Barclays
United Kingdom
$395K +$534K +10,384 New
Raymond James Financial
40
Raymond James Financial
Florida
$394K +$532K +10,347 New
Swiss National Bank
41
Swiss National Bank
Switzerland
$381K +$514K +10,000 New
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$366K +$35.5K +691 +8%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$294K +$362K +7,042 +1,039%
Jane Street
44
Jane Street
New York
$289K +$391K +7,604 New
Bank of America
45
Bank of America
North Carolina
$268K +$29.9K +581 +9%
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$266K +$107K +2,079 +42%
Balyasny Asset Management
47
Balyasny Asset Management
Illinois
$220K +$297K +5,778 New
Bank of Montreal
48
Bank of Montreal
Ontario, Canada
$217K +$293K +5,710 New
HF
49
HRT Financial
New York
$217K -$48.3K -939 -14%
TI
50
Trexquant Investment
Connecticut
$211K +$285K +5,539 New
1
2
3 4

KRRO Hedge Fund Activity: Q4 2024 in Review

84 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q4 2024, worth a combined $360M — up 26% from $285M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new KRRO positions and 9 closed out — a net gain of 15 holders — while 33 added to existing stakes and 14 trimmed.

The largest buyer was AllianceBernstein, opening a new position worth an estimated $36.3M. The largest seller was Eventide Asset Management, cutting an estimated $14.1M.

  • 84 institutional investors held Korro Bio (KRRO) as of Q4 2024, up from 71 in Q3 2024.
  • Funds reported $360M of Korro Bio stock for Q4 2024, up 26% quarter-over-quarter.
  • 24 funds opened new Korro Bio positions in Q4 2024 and 9 closed out, a net change of +15 holders.
  • The largest Korro Bio buyer in Q4 2024 was AllianceBernstein, an estimated $36.3M added.
  • The largest Korro Bio seller in Q4 2024 was Eventide Asset Management, an estimated $14.1M sold.

Based on aggregated 13F filings for Q4 2024.